This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bronchitis Treatment Market

Market Insights on Bronchitis Treatment covering sales outlook, demand forecast & up-to-date key trends

Bronchitis Treatment Market: Global Industry Analysis and Opportunity Assessment 2022-2032

Bronchitis Treatment Market Overview

The global Bronchitis Treatment Market was valued at around US$ 5.5 Bn at the end of 2021. The market is projected to register a 4.1% CAGR and top a valuation of US$ 8.5 Bn by 2032.

“Rising geriatric population worldwide and increasing patient pool with bronchitis and other respiratory disorders are variables expected to set the tone of bronchitis treatment market.”

A medical condition called bronchitis causes the bronchial tubes to become inflamed, which results in coughing, usually with mucus. Dyspnea (shortness of breath), a cough that produces mucus, wheezing while breathing, and chest pain are all signs of bronchitis.

Bronchitis risk factors include viral or bacterial infections, ;smoking, gastric reflux, and ;exposure to irritants at work such as ;dust, ;pollution, ;and others. Pneumonia is one of the most frequent side effects of bronchitis and often happens when the infection progresses deeper into the lungs. Thus, the fluid in the lungs' air sacs fills up due to this illness.

Attributes

Details

Bronchitis Treatment Market Value in 2021

US$ 5.5 Bn

Bronchitis Treatment Market Value in 2032

US$ 8.5 Bn

Bronchitis Treatment Market CAGR (2022-2032)

4.1%

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Major Drivers Boosting the Demand for Bronchitis Treatment Market?

The aging ;population with a higher incidence of bronchitis, higher levels of toxic chemicals and pollutants, and exposure to dust in the workplace or environment are major factors propelling the growth of the ;market. Additionally, people with a history of bronchitis in their families may have it more frequently.

For instance, one of the main factors fueling the expansion of the market for bronchitis treatments is the rising prevalence of smoking. In the US, over 32,000 ;million people used cigarettes in 2020, according to the CDC.

Significant ;factors that can have a major impact on the revenue growth of the global bronchitis treatment market include government-led initiatives to increase treatment awareness and market penetration of the key players ;in developing economies. The treatment of COPD has advanced, including the use of small-cell therapy and combination medications. Additionally, nonpharmacological treatments have become more popular over time.

Which Region Shows Strong Growth Potential in the Bronchitis Treatment Market?

The bronchitis treatment market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

A huge chunk of the global market belongs to North America because of the region's developed healthcare infrastructure and the ;population's awareness of health issues.

Apart from North America, the European market is also anticipated to grow at a rapid pace, due to the rising prevalence of chronic bronchitis and increasing healthcare expenditure by European Commissions.

Furthermore, the Asia Pacific region is also expected to uplift the revenue of the bronchitis treatment market due to the high presence of pollutants in numerous developing economies in Asia which has led to extensive R&D activities in the region to reduce the morbidity of chronic bronchitis.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Manufacturers in the Bronchitis Treatment Market?

Melinta Therapeutics, AstraZeneca, Pfizer Inc., Abbot, GlaxoSmithKline Plc., Cadila Healthcare Limited., Sanofi SA., Novartis, Glenmark, Cipla Inc, Dr. Reddy's Laboratories Ltd., Boehringer Ingelheim Pharmaceuticals, Inc.

Scope of Report

Report Attributes

Details

Growth Rate

CAGR of 4.1% 2022-2032

Base Year for Estimation

2021

Historical Data

2012-2021

Forecast Period

2022-2032

Qualitative Units

Revenue in USD Billion, and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

Segment Covered

  • Type
  • Treatment
  • Drug Class
  • Distribution Channel
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Players

  • Melinta Therapeutics
  • AstraZeneca
  • Pfizer Inc.
  • Abbot
  • GlaxoSmithKline Plc.
  • Cadila Healthcare Limited.
  • Sanofi SA.
  • Novartis
  • Glenmark
  • Cipla Inc
  • Dr. Reddy's Laboratories Ltd.
  • Boehringer Ingelheim Pharmaceuticals, Inc.

Customization

Available Upon Request

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Key Segments Covered in the Bronchitis Treatment Industry Survey

By Type:

  • Chronic Bronchitis
  • Acute Bronchitis

By Treatment:

  • Drugs
  • Oxygen Therapy

By Drug Class:

  • Antibiotics
  • Anti-inflammatory Drugs
  • Bronchodilator
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The market is likely to register a CAGR of 4.7% through 2032.

The market is currently valued at US$ 3.83 Mn in 2022.

The market is likely to grow to a valuation of US$ 6.06 Mn by 2032.

North America is likely to be a leading market during the forecast period.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Aflatoxicosis Treatment Market

Published : July 2017

Healthcare

Scabies Treatment Market

Published : April 2016

Healthcare

Allergy Treatment Market

Published : April 2016

Healthcare

Dysmenorrhea Treatment Market

Published : January 1970

Google translate

Bronchitis Treatment Market